Overall- great experience though
Glucomannan, psyllium, inulin, beta-glucan, and resistant maltodextrin form viscous gels that slow gastric emptying and blunt postprandial glucose
Beyond its well-established role in glucose control in diabetes mellitus, GLP-1 has increasingly become the target of anti-inflammatory therapies for the management of conditions such as atherosclerosis, nonalcoholic steatohepatitis, nephropathy secondary to diabetes, and neurodegenerative disorders [44]
American Association of Clinical Endocrinology
The strongest clinical application: persistent post-concussion symptoms should not automatically be treated as only psychiatric
This gel slows digestion and the release of glucose into your bloodstream, preventing sugar spikes and triggering GLP-1 release